Drug Interaction Report

Sibutramine and Buprenorphine: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Buprenorphine

Belbuca Brixadi Buprenex BuTrans Simbadol Sublocade Zorbium
+

Sibutramine

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 51 documented Sibutramine interactions, 46 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Combining buprenorphine and sibutramine carries a theoretical risk of serotonin syndrome from additive serotonergic effects. Keep taking both as prescribed, watch for symptoms like agitation, sweating, shivering, or a racing heart, and report them to your care team right away.

Both buprenorphine (a pain and addiction medicine) and sibutramine (a weight-loss drug) can raise the level of a brain chemical called serotonin. When two medicines do this at once, there is a small chance of too much serotonin building up, a condition called serotonin syndrome.

Signs to watch for include feeling agitated or confused, a fast heartbeat, sweating, shivering, muscle twitching, or shaking. This is mostly a theoretical concern, but it is worth knowing. The good news is your care team can manage this safely by watching you closely, especially when you first start or change a dose. Please talk with your doctor or pharmacist before changing anything.

Effect: Additive serotonergic activity may increase the risk of serotonin syndrome. Buprenorphine has modest serotonergic properties; sibutramine inhibits reuptake of serotonin (and norepinephrine), so combined use is additive at the pharmacodynamic level. Neither is a prodrug relevant to this mechanism.

  • Direction: Additive PD effect, increased serotonergic tone.
  • Severity/Evidence: Major, but theoretical.
  • Onset: Unspecified; highest risk at initiation and dose changes.
  • Management: Use with caution. Monitor for agitation, hyperthermia, autonomic instability, clonus, hyperreflexia. Discontinue buprenorphine if serotonin syndrome is suspected.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

An increased risk of serotonin syndrome

Interaction Deep Dive

Because of the risk of serotonin syndrome, use buprenorphine cautiously alongside other drugs that influence the serotonergic neurotransmitter system. When such combined therapy cannot be avoided, watch for signs of serotonin syndrome, especially when starting treatment and when doses are modified21. If serotonin syndrome is suspected, stop buprenorphine1.

Why it happens (mechanism)

Additive serotonergic effects

How to manage this interaction

If you are prescribed both medicines, your care team can manage this combination safely.

  • Keep taking both as prescribed unless your doctor or pharmacist tells you otherwise. Do not stop on your own.
  • Your team may monitor you more closely, especially when you first start either drug or when a dose is changed.
  • Watch for agitation, confusion, fast heartbeat, sweating, shivering, muscle twitching, or shaking, and seek care promptly if these appear.
  • Ask your pharmacist to review all your medicines and supplements for other serotonergic agents.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Sibutramine and Buprenorphine together?

Combining buprenorphine and sibutramine carries a theoretical risk of serotonin syndrome from additive serotonergic effects. Keep taking both as prescribed, watch for symptoms like agitation, sweating, shivering, or a racing heart, and report them to your care team right away. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Sibutramine and Buprenorphine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Sibutramine and Buprenorphine interaction managed?

If you are prescribed both medicines, your care team can manage this combination safely. Keep taking both as prescribed unless your doctor or pharmacist tells you otherwise. Do not stop on your own. Your team may monitor you more closely, especially when you first start either drug or when a dose is changed. Watch for agitation, confusion, fast heartbeat, sweating, shivering, muscle twitching, or… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Sibutramine or Buprenorphine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (2)

  1. Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
  2. Product Information: PROBUPHINE(R) subdermal implant, buprenorphine subdermal implant. Braeburn Pharmaceuticals Inc (per FDA), Princeton, NJ, 2016.
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.